WIJKSTROM JOAKIM (SVP, Chief Marketing Officer) sold 11.4% of their position (16.73K shares) of VANDA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $71.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2024ACC: 0000950170-24-027259
Officer· SVP, Chief Marketing Officer
Since Aug 2019
-16.73K
Net shares
Net seller
$71.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.50K
Price / share
$4.41
Trade value
$33.09K
% of position
5.1%
3/4/2024
146.52K→139.02K
Common Stock
Direct
Shares
−9.23K
Price / share
$4.21
Trade value
$38.83K
% of position
6.6%
3/5/2024
139.02K→129.79K
Total
Net shares
−16.73K
Net value
-$71.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2024 | S · Sale | −7.50K | $4.41 | $33.09K | 5.1% | 146.52K | 139.02K |
| Common Stock Direct | 3/5/2024 | S · Sale | −9.23K | $4.21 | $38.83K | 6.6% | 139.02K | 129.79K |
| Total | −16.73K | -$71.92K | ||||||
Derivative Transactions0
No derivative transactions reported